Important Notes

Practical considerations for safe and effective weekly administration.

• Weekly consistency: Choose a specific day/time for your weekly injection and maintain this schedule throughout the protocol.
• Gradual titration is essential: Starting at 2 mg weekly (versus higher doses) significantly reduces initial gastrointestinal side effects^[4].
• Vial size selection: Choose vial size based on your dose requirements - larger vials (20 mg, 30 mg) offer better value for higher dose protocols.
• Use new sterile insulin syringes for each injection; dispose immediately in a puncture-proof sharps container^[14].
• Rotate injection sites weekly (abdomen, thighs, upper arms) at least 1 inch apart to prevent local irritation or lipohypertrophy^[15].
• For doses exceeding 1.0 mL, either split into multiple injections at different sites or use multiple vials as needed.
• Monitor for gastrointestinal side effects (nausea, diarrhea); if severe, consider extending the time at current dose before escalating.
• For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

How This Works

Retatrutide is a first-in-class triple agonist that simultaneously activates three key metabolic hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon^[1][5]. This triple mechanism produces synergistic effects on appetite suppression, energy expenditure, and glucose metabolism that exceed single or dual agonists.

The GLP-1 component reduces appetite and slows gastric emptying; GIP enhances insulin secretion and may support fat metabolism; glucagon receptor activation increases energy expenditure and promotes fat oxidation^[5][8]. With an extended half-life of approximately 6 days, retatrutide enables convenient once-weekly dosing while maintaining therapeutic levels^[1].

In clinical trials, participants receiving 12 mg weekly retatrutide lost an average of 24% of their body weight over 48 weeks^[2]. In adults with type 2 diabetes, retatrutide (up to 12 mg weekly) achieved approximately 17% weight loss at 36 weeks alongside HbA1c reductions of approximately 2.0% compared to placebo^[3]. A 2025 meta-analysis of three trials (878 participants) confirmed retatrutide achieved significantly greater weight reduction than placebo (mean difference approximately 14% of body weight) with no significant increase in overall adverse events^[6][7].

Potential Benefits & Side Effects

Observations from phase 2 and phase 3 clinical trials in humans.

Potential Benefits

• Substantial weight loss: Up to 24% reduction in body weight at 48 weeks with 12 mg weekly dosing^[2].
• Glycemic improvement: Significant HbA1c reductions (approximately 2.0%) in adults with type 2 diabetes^[3].
• Metabolic benefits: Improvements in lipid profiles, blood pressure, and cardiovascular risk markers^[1][5].
• Convenient dosing: Once-weekly subcutaneous administration improves adherence compared to daily regimens^[1].

Common Side Effects

• Gastrointestinal effects: Nausea, diarrhea, vomiting, and constipation are the most common adverse events; typically mild-to-moderate and diminish over time^[2][4].
• Starting at 2 mg weekly (versus 4 mg) significantly reduces initial GI adverse events^[4].
• Injection site reactions: Mild redness, swelling, or discomfort at injection sites may occur; rotate sites to minimize.
• Overall safety profile: Meta-analysis found no significant increase in overall adverse events compared to placebo^[6][7].

Lifestyle Factors

Complementary strategies to optimize outcomes during retatrutide protocols.

• Nutrition: Adopt a balanced, protein-forward diet (1.0–1.2 g/kg body weight) to preserve lean mass during weight loss^[10].
• Hydration: Maintain adequate fluid intake, especially during dose titration when GI effects are most common.
• Physical activity: Combine resistance training (2–3×/week) with moderate aerobic exercise to support metabolic adaptations and preserve muscle mass.
• Sleep & stress: Prioritize 7–9 hours of quality sleep and implement stress management techniques to support hormonal balance and adherence.
• Meal timing: Some individuals find smaller, more frequent meals help manage GI side effects during initial titration.

Injection Technique

Subcutaneous injection guidelines based on clinical best practices and CDC recommendations^[13][14].

Pre-Injection Preparation

• Wash hands thoroughly with soap and water^[14].
• Clean the vial stopper with an alcohol swab and allow to air dry.
• Select injection site (abdomen, thigh, or upper arm) and clean with a fresh alcohol swab; allow to dry completely^[13].
• Draw prescribed dose carefully; check for air bubbles and expel if present.

Injection Procedure

• Pinch a skinfold of approximately 1 inch between thumb and forefinger^[15].
• Insert needle at a 90-degree angle (45-degree if subcutaneous fat layer is thin) into the pinched skin^[13][14].
• Do not aspirate for subcutaneous injections (aspiration is not required and may increase discomfort)^[13].
• Inject slowly and steadily; depress plunger completely.
• Withdraw needle straight out and apply gentle pressure with clean gauze if needed.

Post-Injection Care

• Dispose of used syringe immediately in a puncture-proof sharps container; never recap needles^[14].
• Return reconstituted vial to refrigerator promptly.
• Rotate injection sites weekly (at least 1 inch apart) to prevent lipohypertrophy^[15].
• Monitor for excessive redness, swelling, or signs of infection at injection site.

Recommended Source

We recommend Shop Peptides Direct for high‑purity Retatrutide in all vial sizes (5 mg, 10 mg, 20 mg, 30 mg).

Why Shop Peptides Direct?

• High‑purity, third‑party‑tested lots with batch COAs.
• Consistent, ISO‑aligned handling and documentation.
• Reliable fulfillment to maintain cold‑chain integrity.
• Multiple vial sizes to match different protocol needs.